Global Stem Cells Market is valued at approximately USD 11.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 11.4% over the forecast period 2022-2029. Stem cells are cells that serve as a repair system for the body and have the potential to develop into various types of cells in the body. These cells are used to cure a wide range of diseases and illnesses in the body. The rising expenditure on the development of precision medicine, the growing focus on clinical trials, and the increasing number of cell therapy production facilities are the key driving factors for market growth around the world. The need for stem cell therapy in the treatment of several chronic diseases such as cancer, alzheimer’s, and parkinson’s disease is constantly growing which is fueling the market demand. According to Alzheimer's Disease International (ADI), more than 55 million people worldwide are estimated to be suffering from dementia as of 2020. Additionally, it is estimated that this number reach 78 million by 2030. Consequentially, stem cells are considered an effective treatment option compared with traditional therapies in the treatment of Alzheimer's Disease and other target ailments, thus, in turn, accelerating the growth of the market. Furthermore, increasing investment in research activities related to stem cell production, storage, and characterization, as well as, surging demand for stem cell banking is anticipated to reinforce the growth of the stem cell market. However, the ethical concern associated with stem cell research and the unavailability of a suitable regulatory framework in certain applications of stem cells is restricting the market growth over the forecast period of 2022-2029. The key regions considered for the Global Stem Cells Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the development of the biotechnology industry, high R&D activities in the field of personalized medicines, and the presence of key market players. Whereas, the Asia Pacific is also expected to grow at the highest growth rate over the forecasting period. Factors such as increasing government funding to accelerate research on stem cells and increasing incidences of target diseases including neurological disorders, cancer, and diabetes are burgeoning the market growth in the forecasting years. Major market players included in this report are: Advanced Cell Technology Inc. STEMCELL Technologies Inc. Cellular Engineering Technologies Inc. CellGenix GmbH PromoCell GmbH Kite Pharma Lonza Cellartis AB Angel Biotechnology Brainstorm Cell Therapeutics Recent Developments in the Market:  In January 2021, Celularity Inc. and GX Acquisition Corp. announced that the companies entered into a collaborative agreement, which aims to boost the production & development of innovative allogeneic cell therapies like CAR T cell therapies that are derived from the postpartum placenta and genetically modified natural killer (NK) cell therapies.  In March 2021, OrganaBio announced the launch of its HematoPAC ASC-cb CD34 hematopoietic stem cell product with the objective of supporting HSC-based allogeneic cell therapies. Global Stem Cells Market Report Scope: Historical Data 2019-2020-2021 Base Year for Estimation 2021 Forecast period 2022-2029 Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends Segments Covered Product, Technology, Therapy, Application, End-user, Region Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope* The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study. The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Product: Adult Stem Cells (ASCs) Human Embryonic Stem Cells (HESCs) Induced Pluripotent Stem Cells (iPSCs) Very Small Embryonic Like Stem Cells By Technology: Cell Acquisition Cell Production Cryopreservation Expansion and Sub-Culture By Therapy: Autologous Allogenic By Application: Regenerative Medicine Drug Discovery and Development By End-user: Pharmaceutical and Biotechnology Companies Hospitals & Cell Banks Academic & Research Institutes By Region: North America U.S. Canada Europe UK Germany France Spain Italy ROE Asia Pacific China India Japan Australia South Korea RoAPAC Latin America Brazil Mexico ROLA Rest of the World